These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6128922)

  • 41. Formulary decisions concerning cephalosporins.
    Fuentes RJ
    Am J Hosp Pharm; 1979 Mar; 36(3):296, 300. PubMed ID: 420220
    [No Abstract]   [Full Text] [Related]  

  • 42. Physician attitudes and prescribing practices: a focus on minor tranquilizers.
    Chambers CD; White OZ; Lindquist JH
    J Psychoactive Drugs; 1983; 15(1-2):55-9. PubMed ID: 6136571
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluating incorporation of drug restrictions into computerized drug order entries after transition to an electronic health record.
    Rodriguez R; Staley B; Hatton RC
    Hosp Pharm; 2013 Jul; 48(7):568-73. PubMed ID: 24421522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of a hospital formulary on prescribing habits and drug costs.
    Feely J; Chan R; Cocoman L
    Ir Med J; 1987 Oct; 80(10):286-7. PubMed ID: 3692735
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of benzodiazepine prescription.
    Wolfe SM; Lurie P
    JAMA; 1992 Jul 22-29; 268(4):472; author reply 474. PubMed ID: 1352360
    [No Abstract]   [Full Text] [Related]  

  • 46. Benzodiazepine prescription regulation. Autonomy and outcome.
    Glass RM
    JAMA; 1991 Nov; 266(17):2431-3. PubMed ID: 1681123
    [No Abstract]   [Full Text] [Related]  

  • 47. Re-evaluation of a method of prescribing drugs in hospital.
    Moir DC; Hedley EA
    Health Bull (Edinb); 1971 Jul; 29(3):131-6. PubMed ID: 5565559
    [No Abstract]   [Full Text] [Related]  

  • 48. Regulation of benzodiazepine prescription.
    Levin AA
    JAMA; 1992 Jul 22-29; 268(4):473; author reply 474. PubMed ID: 1352362
    [No Abstract]   [Full Text] [Related]  

  • 49. [Editorial: Patients' errors].
    Andersen V
    Ugeskr Laeger; 1973 Oct; 135(40):2168. PubMed ID: 4789484
    [No Abstract]   [Full Text] [Related]  

  • 50. From knowledge to action: improving drug prescribing.
    Moulds RF
    Med J Aust; 1996 Sep; 165(6):299-300. PubMed ID: 8862324
    [No Abstract]   [Full Text] [Related]  

  • 51. Closed-circuit television prescribing.
    Thomson W
    Nurs Mirror Midwives J; 1976 Jun; 142(25):64-5. PubMed ID: 1047375
    [No Abstract]   [Full Text] [Related]  

  • 52. Experience with a drug formulary in a large Italian city hospital.
    Zaccara A; Sirtori CR; Marchesi F
    Pharmacol Res; 1989; 21(1):51-7. PubMed ID: 2726665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational drug therapy--rational prescriber a priority!
    Amdekar YK
    Indian Pediatr; 1991 Oct; 28(10):1107-9. PubMed ID: 1797661
    [No Abstract]   [Full Text] [Related]  

  • 54. Design and preparation of a formulary--guide to the prescribing of medicines.
    Tugwell AC; Thurston DR; Barrett CW
    J Clin Hosp Pharm; 1984 Dec; 9(4):311-9. PubMed ID: 6526950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated formulary printing from a computerized drug information file.
    Frankenfeld FM; Black HJ; Dick RW
    Am J Hosp Pharm; 1971 Mar; 28(3):155-61. PubMed ID: 5563685
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug discard patterns in long-term care facilities.
    Ciullo JJ; Shepherd MD
    J Am Pharm Assoc; 1977 Dec; 17(12):739-40, 743. PubMed ID: 591690
    [No Abstract]   [Full Text] [Related]  

  • 57. Restricting benzodiazepine prescribing.
    Woods JH; Katz JL; Winger GD
    Lancet; 1991 Feb; 337(8736):295. PubMed ID: 1671128
    [No Abstract]   [Full Text] [Related]  

  • 58. Interventions to improve antibiotic prescribing practices for hospital inpatients.
    Davey P; Marwick CA; Scott CL; Charani E; McNeil K; Brown E; Gould IM; Ramsay CR; Michie S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003543. PubMed ID: 28178770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacoeconomic consequences of measurement and modification of hospital drug use.
    Ioannides-Demos LL; Eckert GM; McLean AJ
    Pharmacoeconomics; 1992 Jul; 2(1):15-33. PubMed ID: 10146976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Economic impact of cost-containment strategies in third party programmes in the US. Part II.
    Kozma CM; Schulz RM; Dickson WM; Dye JT; Cox ER; Holdford DA; Michael L; Yates WN; Young TL
    Pharmacoeconomics; 1993 Sep; 4(3):187-202. PubMed ID: 10146922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.